Abstract
Burkholderia have potential as biocontrol agents because they encode diverse biosynthetic gene clusters (BGCs) for a range of antimicrobial metabolites. Given the opportunistic pathogenicity associated with Burkholderia species, heterologous BGC expression within non-pathogenic hosts is a strategy to construct safe biocontrol strains. We constructed a yeast-adapted Burkholderia-Escherichia shuttle vector (pMLBAD_yeast) with a yeast replication origin 2 μ and URA3 selection marker and optimised it for cloning BGCs using the in vivo recombination ability of Saccharomyces cerevisiae. Two Burkholderia polyyne BGCs, cepacin (13 kb) and caryoynencin (11 kb), were PCR-amplified as three overlapping fragments, cloned downstream of the pBAD arabinose promoter in pMLBAD_yeast and mobilised into Burkholderia and Paraburkholderia heterologous hosts. Paraburkholderia phytofirmans carrying the heterologous polyyne constructs displayed in vitro bioactivity against a variety of fungal and bacterial plant pathogens similar to the native polyyne producers. Thirteen Paraburkholderia strains with preferential growth at 30°C compared with 37°C were also identified, and four of these were amenable to genetic manipulation and heterologous expression of the caryoynencin construct. The cloning and successful heterologous expression of Burkholderia biosynthetic gene clusters within Paraburkholderia with restricted growth at 37°C opens avenues for engineering non-pathogenic biocontrol strains.
Original language | English |
---|---|
Pages (from-to) | 2547-2561 |
Number of pages | 15 |
Journal | Microbial biotechnology |
Volume | 15 |
Issue number | 10 |
DOIs | |
Publication status | Published - 13 Jul 2022 |
Bibliographical note
Funding Information:YDP is funded by a Biotechnology and Biological Sciences Research Council (BBSRC) South West doctoral training partnership award (BV19107109). We acknowledge additional funding from BBSRC grants BB/S007652/1 (EM, AJM and GW) and BB/S008020/1 (JZ and GLC). We thank Tania Chancellor and Javier Palma-Guerrero from the take-all team at Rothamsted Research for providing Gaeumannomyces tritici isolate Gt19LH(4)19d2, which was isolated as part of their Designing Future Wheat strategic programme.
Funding Information:
YDP is funded by a Biotechnology and Biological Sciences Research Council (BBSRC) South West doctoral training partnership award (BV19107109). We acknowledge additional funding from BBSRC grants BB/S007652/1 (EM, AJM and GW) and BB/S008020/1 (JZ and GLC). We thank Tania Chancellor and Javier Palma‐Guerrero from the take‐all team at Rothamsted Research for providing isolate Gt19LH(4)19d2, which was isolated as part of their Designing Future Wheat strategic programme. Gaeumannomyces tritici
Publisher Copyright:
© 2022 The Authors. Microbial Biotechnology published by Society for Applied Microbiology and John Wiley & Sons Ltd.